ロード中...
A new meningococcal conjugate vaccine: What should physicians know and do?
A quadrivalent meningococcal conjugate vaccine for serogroups A, C, Y and W135 (MCV4 [Menactra, sanofi pasteur, Canada]) was introduced in Canada in 2007 for persons two years of age or older. MCV4 adds three serogroups to the meningococcal serogroup C conjugate vaccine, which has been used for seve...
保存先:
| 主要な著者: | , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Pulsus Group Inc
2009
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2780966/ https://ncbi.nlm.nih.gov/pubmed/20885803 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|